| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |